Nader Dakak is a Cardiology physician affiliated with National Institutes of Health. OpenAlex indexes 22 publications with 1,763 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12150 Annapolis Rd
Suite 105
Glenn Dale, MD 207699183
Telephone
301-805-1250Registry record last updated 24 Jun 2011.
Industry payments
39 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202512 payments
- Medtronic, Inc.Program year20251 payment
- Edwards Lifesciences CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
93.4%Adenosine Receptor Agonist62.1%Adenosine100%Part B, office-administered≥136 patientsBeta blocker7.4%Metoprolol Succinate56%Metoprolol Tartrate24%Carvedilol18%Nebivolol Hcl2%Part D<11 patients+ 16 more classes in this area
Blood & clotting
5.2%Factor Xa inhibitor2.8%Eliquis83%Xarelto17%Part D<11 patientsP2Y12 inhibitor2.4%Clopidogrel84%Brilinta17%Part D≥47 patientsMetabolism & gastrointestinal
1%SGLT2 inhibitor0.4%Farxiga52%Jardiance48%Part D<11 patientsPotassium supplement0.3%Potassium Chloride100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Platelet inhibitory effect of nitric oxide in the human coronary circulation: impact of endothelial dysfunction
Journal of the American College of Cardiology
2001 - Nitric Oxide Activity in the Atherosclerotic Human Coronary Circulation
Journal of the American College of Cardiology
1997 - Effect of l-Arginine on Human Coronary Endothelium-Dependent and Physiologic Vasodilation
Journal of the American College of Cardiology
1997
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Pavletic, MD
National Institutes of Health
Theo Heller, MD
National Institutes of Health
John Beigel, MD
National Institutes of Health
Salina Waddy
National Institutes of Health
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”